Plasma Angiotensin II Is Increased in Critical Coronavirus Disease 2019

Global pandemics interconnected — obesity, impaired metabolic health and COVID-19

(2021) Norbert Stefan et al.   Nature Reviews Endocrinology

COVID-19 and the human innate immune system

(2021) Joachim L. Schultze et al.   CELL

Obesity in COVID-19 era, implications for mechanisms, comorbidities, and prognosis: a review and meta-analysis

(2021) Seyed Morsal Mosallami Aghili et al.   INTERNATIONAL JOURNAL OF OBESITY

Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin–Kallikrein System in Severe COVID-19

(2021) Eli Mansour et al.   Viruses-Basel

Prognostic Values of Serum Ferritin and D-Dimer Trajectory in Patients with COVID-19

(2021) Fares Qeadan et al.   Viruses-Basel

D-Dimer Level and Neutrophils Count as Predictive and Prognostic Factors of Pulmonary Embolism in Severe Non-ICU COVID-19 Patients

(2021) Benjamin Thoreau et al.   Viruses-Basel

Myoglobin and C-reactive protein are efficient and reliable early predictors of COVID-19 associated mortality

(2021) Ashaq Ali et al.   Scientific Reports

Biomarkers in COVID-19: An Up-To-Date Review

(2021) Madhusudan Samprathi et al.   Frontiers in Pediatrics

Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients

(2021) Ikram Omar Osman et al.   Frontiers in Immunology

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

(2020) Zunyou Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia

(2020) Feng Pan et al.   RADIOLOGY

Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury

(2020) Yingxia Liu et al.   Science China-Life Sciences

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

(2020) Markus Hoffmann et al.   CELL

Decreased Mortality of COVID-19 with Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients with Hypertension: A Meta-Analysis

(2020) Xiaoming Guo et al.   HYPERTENSION

Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19

(2020) Hisashi Kai et al.   HYPERTENSION RESEARCH

Severe Covid-19

(2020) David A. Berlin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mild or Moderate Covid-19

(2020) Rajesh T. Gandhi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cell entry mechanisms of SARS-CoV-2

(2020) Jian Shang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

(2020) Xiuyuan Ou et al.   Nature Communications

Angiotensin II receptors: Impact for COVID ‐19 severity

(2020) Hasan Aksoy et al.   Dermatologic Therapy

Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report

(2020) Brandon Michael Henry et al.   PROGRESS IN CARDIOVASCULAR DISEASES

Serum ACE-2, angiotensin II, and aldosterone levels are unchanged in patients with COVID-19

(2020) Marina Rieder et al.   AMERICAN JOURNAL OF HYPERTENSION

Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19

(2020) Benjamin J. Meckiff et al.   CELL

Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus

(2016) Hongjing Gu et al.   Scientific Reports

Mitochondria-produced superoxide mediates angiotensin II-induced inhibition of neuronal potassium current

(2010) Jing-Xiang Yin et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY